• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pfizer still seeking CROs for U.K. site

Pfizer still seeking CROs for U.K. site

June 2, 2011
CenterWatch Staff

Pfizer continues to search for CROs to occupy a U.K. site, but the local council is disappointed by the lack of government action.

Pfizer plans to exit the Sandwich site by the end of 2012, affecting 2,400 employees and 900 on-site contractors. Another 10,000 jobs are under threat at other local businesses, and the council hopes Pfizer can avoid adding to this by moving staff to CROs.

“Pfizer is progressing commercially confidential negotiations with potential CROs and exploring the potential for small spin-out companies to develop from the site,” said the Sandwich Economic Development Task Force.

Moving Pfizer staff and assets to CROs is viewed by the task sorce as the first phase of a five-step transition process. With a core of CROs in place, the task force will look to attract startups and large-scale occupiers to take on whole buildings.

To support this process, the task force made a number of proposals to the government but has been disappointed by the lack of action. Pfizer has already sent ‘at risk of redundancy’ notices to 900 staff, making the next month critical for the future of the Sandwich site.

“If there is to be some form of state aid, it is needed now,” said the task force. Incentives could be used to encourage CROs to occupy the site.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing